Once-daily versus twice-daily administration of ceftazidime in the preterm infant.
Ceftazidime pharmacokinetics in 28 preterm infants (gestational ages, 25.6 to 31.9 weeks) were studied on day 3 of life. Patients with suspected septicemia were randomized on day 1 of life in two groups. One group (n = 13) was administered 25 mg of ceftazidime per kg of body weight once daily, and t...
Tallennettuna:
| Julkaisussa: | Antimicrob Agents Chemother |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
American Society for Microbiology (ASM)
1995
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC162879/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8540714/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.39.9.2048 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|